Skip to content

Intellectual and Developmental Disabilities

Jenny Roraback-Carson, MD

Clinical Instructor

Division of Gerontology and Geriatric Medicine
School of Medicine

Learning Objectives

By the end of this lecture, you should be able to:

  • Identify the medical risks to patients with intellectual disabilities with respect to transitions of care.
  • Describe ways in which communication with and support to caregivers can be strengthened to improve health outcomes for patients with developmental disabilities.
  • Name the unique challenges posed by polypharmacy and psychoactive medications in aging patients with developmental disabilities.

[From the Winter 2017 Geriatric Healthcare Lecture Series]

The NW GWEC acknowledges the Coast Salish peoples of this land, the land
which touches the shared waters of all tribes and bands within the Suquamish, Tulalip and Muckleshoot nations.

© 2020 University of Washington | Website by Montana Banana

This website was made possible by Grant Number U1QHP28742 from the Health Resources and Services Administration (HRSA), an operating division of the U.S. Department of Health and Human Services. Its contents are solely the responsibility of the investigators and do not necessarily represent the official views of HRSA or the U.S. Department of Health and Human Services.